The Impact of Bleomycin Deficit on Survival in Hodgkin's Lymphoma Patients: A Retrospective Study

Luiz Ricardo Soldi, Diogo Henrique Rabelo,Paulo Henrique Rosa da Silva, Victor Luigi Costa Silva,Marcelo José Barbosa Silva

Cancer Treatment and Research Communications（2024）

引用 0|浏览0

暂无评分

摘要

•ABVD chemotherapy for Hodgkin's Lymphoma presents no differences in survival when compared to an AVD protocol.•Radiotherapy is a significant contributing factor for a patient's 5-year survival.•Patient medical history, such as initial B symptoms, and conditions such as high blood pressure are important factors for prognosis.

查看译文

关键词

Lymphoma,Chemotherapy,Bleomycin,Cancer,Survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要